Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to investigate the PK (Pharmacokinetic) of repeated-dose
applications of the Rotigotine transdermal patch in healthy young male and female Korean
subjects to be submitted to MFDS for new drug application approval.